Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 17, 2005 12:21 ET | Source: Amersin Life Sciences Corp.

Amersin Appoints Director

NEW YORK, Nov. 17, 2005 (PRIMEZONE) -- Amersin Life Science Corporation (OTCBB:AMLS) (Frankfurt:HUQ) is pleased to announce the immediate appointment of Mr. Rob Gillingham to its Board of...
October 20, 2005 16:30 ET | Source: Amersin Life Sciences Corp.

Amersin Enters Into Termination Agreement With Chinese Joint Venture Partner

NEW YORK, Oct. 20, 2005 (PRIMEZONE) -- Amersin Life Science Corporation (OTCBB:AMLSE) announced today that it has reached a termination agreement and will be disposing of its interest in the Hubei...
September 15, 2005 17:56 ET | Source: Amersin Life Sciences Corp.

Amersin Notifies Chinese Joint Venture That it Will Not be Providing Additional Funds

NEW YORK, Sept. 15, 2005 (PRIMEZONE) -- Amersin Life Science Corporation (OTCBB:AMLS) Chief Executive Officer, H.Y. (Reid) Li, announced that the company notified the minority partners in its Hubei...
May 18, 2005 09:30 ET | Source: Amersin Life Sciences Corp.

Amersin Announces Delay in Filing Annual Report Due to Auditor's Workload

NEW YORK, May 18, 2005 (PRIMEZONE) -- Amersin Life Science Corporation (OTCBB:AMLS) announced today that delays resulting from workload in the office of its auditors, Moen and Company, will result in...
May 12, 2005 10:38 ET | Source: Amersin Life Sciences Corp.

Amersin Subsidiary Makes Application to State Food and Drug Administration For New Antiviral Drug License

NEW YORK, May 12, 2005 (PRIMEZONE) -- Amersin Life Science Corporation (OTCBB:AMLS) announced today that its subsidiary, Hubei Tongji Benda Ebei Pharmaceutical Co. (Hubei Benda), has applied to the...
April 06, 2005 09:00 ET | Source: Amersin Life Sciences Corp.

Amersin Subsidiary Receives 30 Million RMB Contract

NEW YORK, April 6, 2005 (PRIMEZONE) -- Amersin Life Science Corporation (OTCBB:AMLS) announced today that its subsidiary, Hubei Tongji Benda Ebei Pharmaceutical Company, has been awarded a 30 million...
March 01, 2005 14:10 ET | Source: Amersin Life Sciences Corp.

Amersin Life Science Announces Appointment of Director

NEW YORK, March 1, 2005 (PRIMEZONE) -- Amersin Life Science Corporation (OTCBB:AMLS), is pleased to announce the appointment Mr. (Harry) Zhihao Jin to its board of directors. Mr. Harry Jin served...
January 31, 2005 06:00 ET | Source: Amersin Life Sciences Corp.

Amersin Announces 30% Increase in Ribavirin Production to Meet Market Demand Following Recent Avian Flu Outbreaks in Asia

NEW YORK, Jan. 31, 2005 (PRIMEZONE) -- Amersin Life Sciences Corporation (OTCBB:AMLS) announced today that its subsidiary, Hubei Tongji Benda Ebei Pharmaceutical Co. Ltd. (HBPharma), will increase...
September 23, 2004 09:00 ET | Source: Amersin Life Sciences Corp.

Hubei Pharmaceutical Group Reports Second Quarter Operational Profit of $681,666

NEW YORK, Sept. 23, 2004 (PRIMEZONE) -- --------------------------------------------------------------------- Operational Results Second Quarter Six Months at a Glance ...
September 14, 2004 13:09 ET | Source: Amersin Life Sciences Corp.

Hubei Pharmaceutical Group to Sell Joint Venture Interest

NEW YORK, Sept. 14, 2004 (PRIMEZONE) -- Hubei Pharmaceutical Group (OTCBB:HBEI) filed notice with the SEC today that it will sell its joint venture interest in Hubei Pharmaceutical Co. Ltd....